AirSculpt 2024 Investor Presentation

AirSculpt is a fast-growing provider of proprietary body contouring procedures with 27 U.S. centers generating $196M in revenue as of December 2023. The company operates in an $11B+ market with only 2% market share, offering premium procedures at $12,000-$13,000 per case with attractive unit economics and high de novo center profitability. With experienced founder-led management and expansion into international markets including Toronto and London, AirSculpt demonstrates strong growth potential in an underserved market.